Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04175509 · ClinicalTrials.gov registry record · Phase 4

Improving Post-Operative Pain and Recovery in Gynecologic Surgery

A Phase 4 study, sponsored by Aultman Health Foundation.

Completed
Registry status
Phase 4
Development phase
40
Enrollment target

NCT04175509 is a Phase 4 study that has completed, run by Aultman Health Foundation. The registered enrollment target is 40 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04175509, a Phase 4 study, has completed, sponsored by Aultman Health Foundation.

COMPLETED
Registry status
Phase 4
Development phase
40 participants
Enrollment target

Study Summary

This is a clinical investigation to determine the efficacy of rectal versus intravenous acetaminophen in patients undergoing a minimally invasive hysterectomy. All women will receive acetaminophen either rectally or intravenously immediately postoperative, prior to extubation. Patient's will be randomly assigned to either the rectal acetaminophen or the intravenous acetaminophen group. Patient outcomes will be measured through a Numeric Rating Scale (NRS) from 0-10 for pain scores, and total opioid consumption measured in morphine milligram equivalent (MME) for the first 24 hours following surgery, or upon discharge, whichever comes first.

Interventions

  • DRUG Intravenous acetaminophen
  • DRUG Rectal acetaminophen

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2019-12-23
Est. Completion 2021-06-01
Phase Phase 4

Sponsor

Aultman Health Foundation

12 total trials

What the Registry Record Tells You About NCT04175509

The ClinicalTrials.gov registry entry for NCT04175509 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Aultman Health Foundation, which has 12 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Intravenous acetaminophen is the first listed.

NCT04175509 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04175509 about?

NCT04175509 is a clinical study titled "Improving Post-Operative Pain and Recovery in Gynecologic Surgery". This is a clinical investigation to determine the efficacy of rectal versus intravenous acetaminophen in patients undergoing a minimally invasive hysterectomy. All women will receive acetaminophen either rectally or intravenously immediately postoperative, prior to extubation. Patient's will be rand...

What is the current status of trial NCT04175509?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 40 participants. The study started on 2019-12-23. Estimated completion is 2021-06-01.

What interventions are being tested in trial NCT04175509?

The interventions under investigation include: Intravenous acetaminophen (DRUG), Rectal acetaminophen (DRUG).

Who is sponsoring clinical trial NCT04175509?

This trial is sponsored by Aultman Health Foundation, which has 12 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.